Bristol-Myers Squibb Co (NYSE: BMY) is 0.94% higher on its value in year-to-date trading and has touched a low of $39.35 and a high of $61.08 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BMY stock was last observed hovering at around $57.04 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $57.09, the stock is 0.63% and -0.50% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 8.17 million and changing 0.09% at the moment leaves the stock 15.08% off its SMA200. BMY registered 13.93% gain for a year compared to 6-month gain of 33.79%. The firm has a 50-day simple moving average (SMA 50) of $57.3772 and a 200-day simple moving average (SMA200) of $49.6075.
The stock witnessed a 0.44% loss in the last 1 month and extending the period to 3 months gives it a 7.27%, and is 2.42% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.17% over the week and 1.78% over the month.
Bristol-Myers Squibb Co (BMY) has around 34100 employees, a market worth around $115.79B and $47.44B in sales. Fwd P/E is 8.19. Profit margin for the company is -15.30%. Distance from 52-week low is 45.08% and -6.53% from its 52-week high. The company has generated returns on investments over the last 12 months (-10.78%).
with sales reaching $11.54B over the same period.The EPS is expected to shrink by -87.98% this year, but quarterly earnings will post 5.45% year-over-year. Quarterly sales are estimated to grow 0.51% in year-over-year returns.
2916.0 institutions hold shares in Bristol-Myers Squibb Co (BMY), with institutional investors hold 79.94% of the company’s shares. The shares outstanding are 2.03B, and float is at 2.03B with Short Float at 1.23%. Institutions hold 79.85% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 186.57 million shares valued at $7.75 billion. The investor’s holdings represent 9.2225 of the BMY Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 158.66 million shares valued at $6.59 billion to account for 7.8428 of the shares outstanding. The other top investors are STATE STREET CORP which holds 91.45 million shares representing 4.5203 and valued at over $3.8 billion, while JPMORGAN CHASE & CO holds 3.6818 of the shares totaling 74.63 million with a market value of $3.1 billion.
Bristol-Myers Squibb Co (BMY) Insider Activity
The most recent transaction is an insider sale by Holzer Phil M, the company’s SVP and Controller. SEC filings show that Holzer Phil M sold 700 shares of the company’s common stock on Nov 04 ’24 at a price of $55.62 per share for a total of $38930.0. Following the sale, the insider now owns 11760.0 shares.
Bristol-Myers Squibb Co disclosed in a document filed with the SEC on Nov 01 ’24 that Hirawat Samit (EVP,Chief Med.Offr.,Drug Dev.) bought a total of 1,830 shares of the company’s common stock. The trade occurred on Nov 01 ’24 and was made at $54.67 per share for $0.1 million. Following the transaction, the insider now directly holds 62109.0 shares of the BMY stock.
Still, SEC filings show that on Nov 04 ’24, Holzer Phil M (Officer) Proposed Sale 700 shares at an average price of $55.62 for $38930.0. The insider now directly holds shares of Bristol-Myers Squibb Co (BMY).
